First Trust NYSE Arca Biotechnology Index Fund
FBT
251 hedge funds and large institutions have $536M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 88 reducing their positions, and 24 closing their positions.
42% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 24
3% more funds holding
Funds holding: 243 → 251 (+8)
1.14% more ownership
Funds ownership: 47.55% → 48.69% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $559M → $536M (-$23.6M)
34% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 88
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$6.1M |
| 2 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$4.01M |
| 3 |
EAM
Empirical Asset Management
Wellesley,
Massachusetts
|
+$3.38M |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
+$3.2M |
| 5 |
NW
NewEdge Wealth
Pittsburgh,
Pennsylvania
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$8.61M |
| 2 |
LPL Financial
San Diego,
California
|
-$7.7M |
| 3 |
Morgan Stanley
New York
|
-$7.49M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.84M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4.66M |
FBT Hedge Fund Activity: Q2 2024 in Review
251 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2024, worth a combined $536M — down 4.2% from $559M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new FBT positions and 24 closed out — a net gain of 10 holders — while 58 added to existing stakes and 88 trimmed.
The largest buyer was Jane Street, adding an estimated $6.1M. The largest seller was Wells Fargo, cutting an estimated $8.61M.
- 251 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2024, up from 243 in Q1 2024.
- Funds reported $536M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2024, down 4.2% quarter-over-quarter.
- 34 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2024 and 24 closed out, a net change of +10 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2024 was Jane Street, an estimated $6.1M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2024 was Wells Fargo, an estimated $8.61M sold.
Based on aggregated 13F filings for Q2 2024.